Genomic Updates To Drug Labeling Could Result From Medco/FDA Partnership

FDA could use results from a new research collaboration with Medco to update existing drug labeling with genomic information. Announced by Medco on Aug. 18, the project calls for the pharmacy benefit management company to draw from its pharmacy claims data base and its own physician and member surveys to produce a series of reports on the impact of genetic testing on drug efficacy and safety